Archive: Artificial Intelligence Could Vastly Scale Up Alzheimer’s Research
Researchers have found a way to teach a computer to precisely detect one of the hallmarks of Alzheimer’s disease in human brain tissue.
University of California San Francisco
Give to UCSFResearchers have found a way to teach a computer to precisely detect one of the hallmarks of Alzheimer’s disease in human brain tissue.
Two proteins central to the pathology of Alzheimer’s disease act as prions – spreading through tissue like an infection by forcing normal proteins to adopt the same misfolded shape.
The technology could one day restore the voices of people who have lost the ability to speak due to paralysis and other forms of neurological damage.
A first-of-its-kind national study has found that a form of brain imaging that detects Alzheimer’s-related “plaques” significantly influenced clinical management of patients with mild cognitive
New UCSF study may have answered how your brain knows when you’ve had enough water.
UCSF researchers developed a strategy for targeting a key molecule implicated in Parkinson’s disease, opening up a potential new treatment strategy for the currently incurable movement disorder.
More than a thousand projects across the University received federal funding from the National Institutes of Health in 2018, totaling more than $647.8 million.
UCSF researchers created a chimpanzee brain “organoids” that mimic the development and organization of full-size brains.
Researchers have discovered that the intestine is the source of immune cells that reduce brain inflammation in people with MS, and that increasing the number of these cells blocks inflammation entirely.
UCSF researchers programmed a machine-learning algorithm to diagnose early-stage Alzheimer’s disease. The algorithm used PET scans – a common type of brain scan.
UCSF experts share their science-backed strategies for aging well.
A growing number of researchers at UCSF and elsewhere have turned their attention to questions around why and how some people who age thrive and are more resilient than others.
From sensory processing disorder to how CRISPR is being explored to bring new treatments to patients, these are the stories that most engaged our readers in 2018.
Anxiety and depression may be leading predictors of conditions ranging from heart disease to headaches, having similar effects as long-established risk factors like smoking and obesity.
Patients with moderate to severe depression reported significant improvements in mood when researchers precisely stimulated a brain region called the orbitofrontal cortex.
Nearly 25 percent of the LGBT adults aged 50 and older in a new study had subjective cognitive decline, a potential indicator of a future Alzheimer’s diagnosis.
The NFL has awarded more than $3.45 million to a UCSF-led research consortium tasked with identifying the causes, risk factors, biomarkers and prognoses for patients with TBI.
Using a mouse model, researchers showed that a drug that temporarily suppresses a key component of the brain’s immune system can prevent radiation-associated cognitive decline.
Genetics may predispose some people to both Alzheimer’s disease and high levels of blood lipids such as cholesterol, a common feature of cardiovascular disease.
An innovative San Francisco program of community choirs for older adults found that singing in a choir reduced loneliness and increased interest in life, but did not improve cognition or physical function.
New research from UCSF has identified a common pattern of brain activity that may be behind feelings of low mood, particularly in people who have a tendency towards anxiety.
UCSF researchers discovered a gene that plays an essential role in noise-induced deafness.
UCSF scientists are working to understand how concussions cause long-term cognitive damage – and how they might be treated.
A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even before changes are identified on scans.